NSE APOLLOHOSP · BSE 508869 · Healthcare Facilities · NIFTY 50

Apollo Hospitals Enterprise Share Price

Market closed · NSE price as of Mon 28 Sep
₹8,860.00 ▼ −₹29.33 · 0.33%
Day range · 28 Sep
₹8,804.35Low₹8,901.20High
52-week range
₹6,680.00Low · 23 Jan 2026₹9,326.80High · 23 Sep 2026

Apollo Hospitals Enterprise Overview

Where the price stands, how it has moved and how it sits against its averages.

Apollo Hospitals Enterprise shares last traded at ₹8,860.00 on the NSE, down 0.33% on the day. That is 5.0% below the 52-week high of ₹9,326.80 and 32.6% above the 52-week low of ₹6,680.00. The stock trades at 60.97× earnings, above the sector average of 30.19. Its market value is ₹1,27,393 Cr.

NSE closing prices — daily for the last year, weekly before that — ending at the latest price (Mon 28 Sep). Hover, tap or use the arrow keys to read a day.

Price returns

1 Day▼ −0.33%
1 Week▼ −0.58%
This month▼ −0.43%
3 Months▲ +3.12%
6 Months▲ +17.37%
This year▲ +25.81%
1 Year▲ +17.98%

Share price growth a year (CAGR): 3 years ▲ +21.1% · 5 years ▲ +13.4% · 10 years ▲ +20.8%

Against the market: 1 Month ▲ +5.16% · 3 Months ▲ +7.94% · 6 Months ▲ +17.25% · This year ▲ +45.56% · 1 Year ▲ +28.05%

Shading grows with the size of the move. We ask our data provider for a newer price every 15 minutes while the market is open (9:15 AM–3:30 PM IST); next check from Fri 16 Oct, 9:15 AM. Its quotes are not real-time — the time at the top shows how current the price is.

Moving averages — price is above 5 of 6

  1. 5-day average₹8,918.80 ▼ price 0.7% below
  2. Today's price₹8,860.00
  3. 10-day average₹8,855.35 ▲ price 0.1% above
  4. 50-day average₹8,840.92 ▲ price 0.2% above
  5. 20-day average₹8,830.55 ▲ price 0.3% above
  6. 100-day average₹8,617.72 ▲ price 2.8% above
  7. 300-day average₹7,973.55 ▲ price 11.1% above

Each average is the mean closing price over that many trading days; averages above the current price sit higher on the ladder.

Apollo Hospitals Enterprise Financial Results

Revenue and net profit in ₹ crore, with the full statements underneath.

Revenue₹ crore
25,229
Net profit₹ crore · losses below zero
1,942

Year by year

Fiscal yearRevenueGrowthNet profitNet marginEPSDividend
FY 2026 ₹25,229 Cr ▲ +15.8% ₹1,942 Cr 7.7% ₹134.95 ₹20.00
FY 2025 ₹21,794 Cr ▲ +14.3% ₹1,446 Cr 6.6% ₹100.56 ₹19.00
FY 2024 ₹19,059 Cr ▲ +14.7% ₹899 Cr 4.7% ₹62.50 ₹16.00
FY 2023 ₹16,613 Cr ▲ +13.3% ₹819 Cr 4.9% ₹56.97 ₹15.00
FY 2022 ₹14,663 Cr ▲ +38.9% ₹1,056 Cr 7.2% ₹73.42 ₹11.75
FY 2021 ₹10,560 Cr ▼ −6.1% ₹150 Cr 1.4% ₹10.74 ₹3.00
FY 2020 ₹11,247 Cr — ₹455 Cr 4.0% ₹32.69 ₹6.00

Balance sheet — FY26

Owes (liabilities)Shareholders' equity
57%
43%
  • Total assets₹22,197 Cr
  • Total liabilities₹12,717 Cr
  • Shareholders' equity₹9,480 Cr
  • Total debt₹8,493 Cr
  • Cash & investments₹1,856 Cr
  • Current ratio1.06×
  • Revenue growth, 5 yr19.03% a year
  • EPS growth, 5 yr65.88% a year
  • Operating margin (TTM)11.71%
  • Net margin (TTM)8.05%

Cash flow — FY26

Operating activities
▲ ₹2,859 Cr
Investing activities
▼ −₹2,148 Cr
Financing activities
▼ −₹478 Cr
Free cash flow
▲ ₹897 Cr
Net change in cash
▲ ₹233 Cr

Right of the line = cash coming in, left = cash going out. Free cash flow = cash from operations minus capital spending.

Full financial statements, FY20–FY26
₹ croreFY20FY21FY22FY23FY24FY25FY26
Total revenue11,246.8010,560.0014,662.6016,612.5019,059.2021,794.0025,228.50
Cost of revenue5,498.905,684.207,573.508,574.309,805.5011,310.0013,075.60
Gross profit5,747.904,875.807,089.108,038.209,253.7010,484.0012,152.90
Operating expenses10,072.109,920.6012,778.3015,160.2017,348.0019,516.0022,343.50
Operating income1,174.70639.401,884.301,452.301,711.202,278.002,885.00
Depreciation619.10572.50600.10614.80686.40756.90875.40
Profit before tax660.00220.701,578.101,143.701,362.502,006.102,616.00
Tax225.2084.70477.00256.20445.50534.00658.20
Net profit454.80150.401,055.60819.10898.601,445.901,941.70
EPS (₹)32.6910.7473.4256.9762.50100.56134.95
Dividend per share (₹)6.003.0011.7515.0016.0019.0020.00

Apollo Hospitals Enterprise vs Peers

Side by side with other healthcare facilities companies. The small bars compare each column.

CompanyPriceChangeMarket capP/EP/BROE (5 yr)Net marginDiv. yield
Apollo Hospitals Enterprise This stock ₹8,860.00 ▼ −0.33% ₹1,27,393 Cr 60.97 13.44 18.12% 8.05% 0.23%
Max Healthcare Institute ₹1,000.90 ▼ −1.29% ₹97,419 Cr 71.47 9.87 13.32% 17.23% 0.18%
Fortis Healthcare ₹831.60 ▼ −0.42% ₹62,782 Cr 67.89 7.27 9.36% 11.66% 0.10%
Aster DM Healthcare ₹748.00 ▼ −1.48% ₹65,283 Cr 102.55 9.26 7.13% 9.20% 0.49%
Narayana Hrudayalaya ₹1,832.00 ▼ −1.58% ₹37,361 Cr 48.07 9.08 25.72% 10.26% 0.22%
Global Health ₹1,433.00 ▼ −4.17% ₹38,683 Cr 63.65 8.93 15.69% 12.56% 0.04%

Peer prices and ratios as last reported by the data provider. Company names link to their own pages.

Shareholding Pattern

Who owns Apollo Hospitals Enterprise shares, quarter by quarter (latest on top).

PromoterFIIMFOther
Jun '26
28.0%
41.5%
17.3%
13.2%
Mar '26
Dec '25
Sep '25
HolderSep '25Dec '25Mar '26Jun '26Change
Promoter28.02%28.02%28.02%28.02% 0.00 pts
FII44.20%43.54%42.62%41.49% ▼ −1.13 pts
MF16.48%16.75%16.65%17.33% ▲ +0.68 pts
Other11.30%11.69%12.71%13.16% ▲ +0.45 pts

Apollo Hospitals Enterprise Key Metrics

Each ratio placed against a benchmark — the sector average, the company's own 5-year average, or a common rule of thumb.

Apollo Hospitals EnterpriseBenchmarkRule-of-thumb bands

Valuation The price against earnings, book value and sales

P/E (TTM)Price ÷ yearly earnings per share
60.97
▲ 102% above the sector average of 30.19
P/E, 12-month rangeLow 54.98 · high 109.63
11%
Today's P/E sits 11% of the way from its low to its high
P/BPrice ÷ book value per share
13.44
P/SMarket cap ÷ last 12 months' revenue
4.82
P/CFPrice ÷ cash flow per share
42.27
PEGP/E ÷ earnings growth rate
1.84

Profitability Of every ₹100 of sales, how much is kept?

Gross marginKept after the cost of goods
48.45%
▲ above its 5-yr average of 48.29%
Operating marginKept after running costs
11.71%
▲ above its 5-yr average of 10.49%
Pre-tax marginKept before tax
10.72%
▲ above its 5-yr average of 8.94%
Net marginKept as profit
8.05%
▲ above its 5-yr average of 6.51%

Returns & efficiency How well does it use its money?

Return on equityProfit on shareholders' money
21.95%
▲ above its 5-yr average of 18.12%
Return on assetsProfit on everything it owns
9.14%
▲ above its 5-yr average of 7.73%
Return on investmentProfit on long-term capital
12.69%
▲ above its 5-yr average of 10.41%
Return on capital employedProfit before interest and tax on equity + debt
16.51%

Growth Is the business getting bigger?

Revenue — last 12 months
+17.2%
▲ growing
Revenue — 3 yr, a year
+14.9%
▲ growing
Revenue — 5 yr, a year
+19.0%
▲ growing
Net profit — 3 yr, a year
+33.3%
▲ growing (off the scale)
Net profit — 5 yr, a year
+66.8%
▲ growing (off the scale)
EPS — last 12 months
+32.7%
▲ growing (off the scale)
EPS — 3 yr, a year
+33.3%
▲ growing (off the scale)
EPS — 5 yr, a year
+65.9%
▲ growing (off the scale)
Dividend — 3 yr, a year
+10.1%
▲ growing
Book value — 5 yr, a year
+15.6%
▲ growing

Financial strength Can it pay its bills and debts?

Debt to equityBorrowings for every ₹1 of shareholders' money
0.90×
• Moderate
Current ratioShort-term assets for every ₹1 due within a year
1.06×
• Adequate
Quick ratioLike the current ratio, without inventory
0.97×
• Adequate
Interest coverOperating profit ÷ interest to pay
14.91×
✓ Strong
Payout ratioShare of profit paid as dividend
14.82%
• Keeps most

Per share What each share stands for

EPS (TTM)
₹145.21
Book value
₹659.26
Cash flow
₹210.14
Dividend
₹20.00
Revenue
₹1,836.73

The share price is 13.44× the book value behind each share.

Benchmarks: sector averages and 5-year averages come from the data provider; the debt and liquidity bands are common rules of thumb, not investment advice.

All 112 metrics from the data provider

Valuation

P/E excluding extraordinary items, most recent fiscal year65.87
Current Dividend Yield - Common Stock Primary Issue, LTM0.23
Price to Book - most recent fiscal year13.48
P/E Basic excluding extraordinary items - TTM59.74
P/E including extraordinary items - TTM61.21
P/E excluding extraordinary items low, trailing 12 months54.98
Price to Tangible Book - most fiscal year15.57
Dividend Yield - 5 Year Average0.28
Price to sales - most recent fiscal year5.07
Dividend Yield - indicated annual dividend divided by closing price0.23
Price to Cash Flow per share - trailing 12 month42.27
Peg Ratio1.84
Price to Free Cash Flow per Share - most recent fiscal year209.73
P/E Normalized, most recent fiscal year65.18
P/E excluding extraordinary items high, trailing 12 months109.63
P/E excluding extraordinary items, most recent fiscal year quarter61.21
Price to sales - trailing 12 month4.84
Net Debt, LFY66,370.00

Per share

Dividend Per Share - 5 year average16.35
Cash Flow per share - trailing 12 month210.14
Cash Flow per share - most recent fiscal year196.91
EPS including extraordinary items - trailing 12 month145.21
EPS including extraordinary items - most recent fiscal year134.95
EBITD per share - trailing 12 month278.64
Revenue/share - trailing 12 month1,836.73
EPS excluding extraordinary items - trailing 12 month145.21
EPS Basic excluding extraordinary items - most recent fiscal year135.04
EPS Basic excluding extraordinary items - trailing 12 month145.33
Book value per share - most recent fiscal year659.33
Dividend per share - most recent fiscal year20.00
Revenue/share - most recent fiscal year1,753.42
EPS Normalized - most recent fiscal year136.37
Book value (tangible) per share - most recent fiscal year570.88
Dividends per share - trailing 12 month20.00
EPS excluding extraordinary items - most recent fiscal year134.95
Cash per share - most recent fiscal year129.08

Margins

Operating margin - trailing 12 month11.71
Gross Margin - 5 year average48.29
Operating margin - 1st historical fiscal year11.44
Operating Margin - 5 year average10.49
Net Profit Margin % - 1st historical fiscal year7.76
Gross Margin - 1st historical fiscal year48.17
Net Profit Margin % - trailing 12 month8.05
Net Profit Margin - 5 year average6.51
Pretax Margin - 5 year average8.94
Pretax margin - 1st historical fiscal year10.37
Pretax margin - trailing 12 month10.72
Free Operating Cash Flow/Revenue, 5 Year Average2.50
Gross Margin - trailing 12 month48.45

Growth

EPS Change %, TTM over TTM32.70
Revenue growth rate, 5 year19.03
EPS growth rate, 5 year65.88
Revenue Change % - most recent quarter 1 year ago20.56
Growth rate% - dividend, 3 year10.06
Growth rate% - EPS, 3 year33.31
Revenue/share (5 yr growth)18.38
Free Operating Cash Flow, 5 Year CAGR−7.97
Tangible Book Value, Total Equity, 5 Year CAGR14.66
Earnings Before Interest, Taxes, Depreciation & Amortization, 5 Year Interim CAGR19.84
Capital Spending growth rate, 5 year46.03
Revenue Change %, TTM over TTM17.20
Growth rate% - Revenue, 3 year14.94
Book value per share growth rate, 5 year15.55
EPS Change % - most recent quarter 1 year ago34.12
Net Profit Margin growth rate, 5 year43.22
Earnings Before Interest, Taxes, Depreciation & Amortization, 5 Year CAGR26.83
Total Debt, 5 Year CAGR15.35

Financial strength

Net Interest coverage - most recent fiscal year14.91
Free Cash Flow - most recent fiscal year6,094.00
LT debt/equity - most recent fiscal year0.54
Quick ratio - most recent fiscal year0.97
Payout ratio - trailing 12 month6.88
Current ratio - most recent fiscal year1.06
Current EV/Free Cash Flow, LFY231.22
Total debt/total equity - most recent fiscal year0.90
Net Interest coverage - trailing 12 month6.74
Payout ratio - most recent fiscal year14.81

Returns & efficiency

Return on average equity - 5 year average18.12
Net Income/employee - trailing 12 month4,83,412.10
Revenue/employee - most recent fiscal year58,32,842.00
Return on investment - most recent fiscal year12.69
Return on average assets - most recent fiscal year9.14
Receivables turnover - most recent fiscal year7.33
Inventory turnover - most recent fiscal year19.94
Revenue/employee - trailing 12 month60,05,704.00
Return on average assets - 5 year average7.73
Net Income/employee - most recent fiscal year4,52,644.30
Asset turnover - most recent fiscal year1.18
Return on average equity - most recent fiscal year21.95
Return on investment - 5 year average10.41

Price & volume

Market Cap1,27,421.96
52 week Low Date23 Jan 2026
Price - 1 Day % Change0.01
Relative (S&P500) price percent change - 13 week7.94
Avg trading volume last 10 days0.30
Price - 13 week price percent change3.46
Price - 52 week price percent change16.59
Avg Trading Volume Last 3 months6.89
Price - 5 Day % Change−0.62
Price % Change Month To Date−0.11
Relative (S&P500) price percent change - 04 week5.16
52 week High Date23 Sep 2026
Price - 26 week price percent change17.75
PDATE25 Sep 2026
Price - YTD price percent change26.22
Relative (S&P500) price percent change - 52 week28.05
NPRICE8,889.00
Relative (S&P500) price percent change - 26 week17.25
52 week Low6,696.50
52 week High9,070.50
Beta0.61
Relative (S&P500) price percent change - Year to Date45.56

Dividends & Corporate Events

Payouts to shareholders, splits and bonus issues, and company meetings — newest first.

Dividend per share₹ per share, by fiscal year
₹20.00
  • Dividend yield0.23%
  • Payout ratio14.82%
  • 5-year average dividend₹16.35 a share
  • Latest dividend₹10.00 per share · 14 Aug 2026

Corporate calendar

  • MeetingAnnual General Meeting
  • MeetingAnnual General Meeting
  • Dividend₹10.00 per share · 200% · Final dividend
  • BoardQuarterly Results
  • MeetingCOM
  • BoardAudited Results & Final Dividend
  • Dividend₹10.00 per share · 200% · Interim dividend
  • BoardQuarterly Results, Int. Dividend & Others
Show 14 older events
  • BoardQuarterly Results
  • MeetingAnnual General Meeting
  • Dividend₹10.00 per share · 200% · Final dividend
  • BoardQuarterly Results & Others
  • BoardAudited Results, Final Dividend & A.G.M.
  • Dividend₹9.00 per share · 180% · Interim dividend
  • BoardQuarterly Results & Interim Dividend
  • BoardQuarterly Results
  • MeetingAnnual General Meeting
  • MeetingPostal Ballot
  • Dividend₹10.00 per share · 200% · Final dividend
  • Dividend₹6.00 per share · 120% · Interim dividend
  • Dividend₹9.00 per share · 180% · Final dividend
  • Dividend₹6.00 per share · 120% · Final dividend

About Apollo Hospitals Enterprise

Healthcare Facilities

Apollo Hospitals Enterprise Limited is an integrated healthcare company. It is engaged in the business of providing hospital services and selling pharma and wellness products through a network of pharmacies, including the operation of multidisciplinary private hospitals, clinics, diagnostic centers and pharmacies. It is engaged in hospitals and hospitals-based services. The Company's segments include Healthcare Services, Retail Health and Diagnostics, Digital Health and Pharmacy Distribution, and Others. The Retail Health and Diagnostics segment include clinics, diagnostics, Spectra, Cradle, Sugar, Dental and Dialysis business. The Digital Health and Pharmacy Distribution segment is engaged in the business of procurement and distribution of pharmaceuticals, fast-moving consumer goods and private label products business from various services using the digital platform. The Company has approximately 10,100 plus beds across 73 hospitals and 6,600 plus pharmacies.

Key people

  • Prathap C. ReddyExecutive Chairman of the Board, Founder
  • Preetha ReddyExecutive Vice Chairman of the Board
  • Krishnan AkhileswaranChief Financial Officer
  • Sankaranarayan Muthu KrishnanSenior Vice President - Finance, Company Secretary
  • Sangita ReddyJoint Managing Director, Executive Director
  • Suneeta ReddyManaging Director, Executive Director

Company facts

  • NSE symbolAPOLLOHOSP
  • BSE code508869
  • ISININE437A01024
  • IndustryHealthcare Facilities
  • IndexNIFTY 50, NIFTY 500
  • Market cap₹1,27,393 Cr
  • Revenue (FY26)₹25,229 Cr
  • Net profit (FY26)₹1,942 Cr

In the News

Recent headlines about Apollo Hospitals Enterprise — they open on Mint in a new tab.

Stock data comes from the exchange feed via our data provider. It is not real-time and can be delayed, so check the price with your broker before you trade. This page is for information and education only. It is not investment advice, research or a recommendation to buy, sell or hold any security. Investments in the securities market are subject to market risks; read all related documents carefully before investing. See all stocks →

Frequently Asked Questions

Apollo Hospitals Enterprise (NSE: APOLLOHOSP) last traded at ₹8,860.00 on the NSE, down 0.33% (₹29.33) on the day, as of 28 Sep 2026. The day's range was ₹8,804.35 – ₹8,901.20.

Apollo Hospitals Enterprise's 52-week high is ₹9,326.80 (23 Sep 2026) and its 52-week low is ₹6,680.00 (23 Jan 2026). At ₹8,860.00 the share is 5.0% below its high and 32.6% above its low.

Apollo Hospitals Enterprise's market capitalisation is ₹1,27,393 Cr (₹1.27L Cr). It is part of the NIFTY 50 index.

Apollo Hospitals Enterprise's P/E ratio (trailing 12 months) is 60.97. The sector average is 30.19, so investors pay 102% more for each rupee of its earnings than for the average company in its sector. Its earnings per share (TTM) are ₹145.21.

Apollo Hospitals Enterprise shares are up 17.98% over the last year, up 25.81% so far this year, up 17.37% over 6 months, up 3.12% over 3 months. Over the last year the stock did 28.05% better than the market.

In FY26 (year to Mar 2026), Apollo Hospitals Enterprise reported revenue of ₹25,229 Cr (up 15.76% on the year before) and a net profit of ₹1,942 Cr. Earnings per share were ₹134.95.

Yes. Apollo Hospitals Enterprise's latest dividend is ₹10.00 per share (200%, final dividend), with an ex-date of 14 Aug 2026. The dividend yield is 0.23%. It has paid 8 dividends in the records shown on this page.

As of Jun 2026: Promoter 28.02%, FII 41.49%, MF 17.33%, Other 13.16%.

Apollo Hospitals Enterprise's listed peers in Healthcare Facilities include Max Healthcare Institute, Fortis Healthcare, Aster DM Healthcare, Narayana Hrudayalaya, Global Health. By market capitalisation it ranks #1 of 6 in this group.

No. Apollo Hospitals Enterprise has debt — its debt-to-equity ratio is 0.90 and total debt was ₹8,493 Cr in FY26. Its operating profit covers interest 14.91 times.